These 10 stocks could mint the next wave of millionaires › Ocugen (NASDAQ:OCGN), a biotechnology company developing gene therapies and regenerative medicine solutions for eye diseases, released its ...

Step into the world of cutting-edge design with these 15 innovative furniture pieces that redefine style and functionality ...

Gain insights from Ocugen's Q2 2025 earnings call, highlighting clinical advancements, strategic partnerships, BLA milestones for 2026-2027, and ...

Emmanuel Clase’s paid leave has screwed up some plans. The news that the All-Star closer is involved in MLB’s sports betting ...

(NASDAQ:MRNA) today reported financial results and provided business updates for the second quarter of 2025. "In the last three months, we advanced our pipeline with positive Phase 3 flu vaccine ...

The United States and Pakistan reached a trade agreement expected to allow Washington to help develop Pakistan's largely ...

A new study led by researchers at the Ineos Oxford Institute for Antimicrobial Research (IOI) has found that ...

The United States and Pakistan reached a trade agreement expected to allow Washington to help develop Pakistan’s largely untapped oil reserves and lower tariffs for the South Asian country, officials ...

uniQure (NASDAQ: QURE) is one of the biotech stocks to buy according to Wall Street analysts. Earlier on June 2, uniQure provided a regulatory update on AMT-130, which is the company’s investigational ...

Explore the latest biosimilar developments, including legislative changes, new approvals, and challenges in understanding, shaping the future of affordable health care.

Exelixis' revenue growth through cabozantinib, mixed trial updates on zanzalintinib, and potential market shifts following ...